Laboratorios Farmaceuticos ROVI (ROVI)

Currency in EUR
55.30
-1.65(-2.90%)
Closed·
ROVI Scorecard
Full Analysis
Stock generally trades with low price volatility
ROVI is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
55.3055.90
52 wk Range
45.8288.45
Key Statistics
Bid/Ask
55.20 / 55.30
Prev. Close
55.3
Open
55.8
Day's Range
55.3-55.9
52 wk Range
45.82-88.45
Volume
-
Average Volume (3m)
190
1-Year Change
-37.37%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ROVI Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Cash flows can sufficiently cover interest payments
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Laboratorios Farmaceuticos ROVI Company Profile

Laboratorios Farmaceuticos Rovi, S.A. manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally. The company offers prescription products, including Ameride, Bertanel, Bluxam, Enoxaparin Rovi, Calcium Vitamine D3 Rovi, Exxiv, Prinvil, Rhodogil, Glufan, Hibor, Hirobriz Breezhaler, Neparvis, Medicebran, Medikinet, Mysimba, Orvatez, Tryptizol, Ulunar Breezhaler, and Volutsa. It also provides hospital products, such as Iomeron and Iopamiro, Multihance and Y Prohance, Sonovue, Empowercta+, Empowermr, and CT Express; catheter care under the Fibrilin brand; and Sodium Heparin Rovi. In addition, the company offers contract-manufacturing services comprising compounding, aseptic filling and terminal sterilisation, inspection, installation of safety devices, labelling, packaging, serialisation and aggregation, for different injectable pharmaceutical forms, such as prefilled syringes, vials and cartridges, as well as manufacturing and packaging services for solid products. Its products are used for cardiology, osteoarticular/women’s health, anesthesia /pain, diagnostic imaging contrast agents, central nervous system, urology, endocrinology, respiratory, and primary healthcare areas. The company was incorporated in 1946 and is headquartered in Madrid, Spain. Laboratorios Farmaceúticos Rovi, S.A. is a subsidiary of Norbel Inversiones, S.L.

Employees
2188
Market
Austria

Compare ROVI to Peers and Sector

Metrics to compare
ROVI
Peers
Sector
Relationship
P/E Ratio
21.6x20.5x−0.5x
PEG Ratio
−2.421.900.00
Price/Book
5.1x2.3x2.6x
Price / LTM Sales
3.8x2.3x3.3x
Upside (Analyst Target)
-12.2%42.4%
Fair Value Upside
Unlock20.9%7.2%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 2.59%
Dividend Yield
1.37%
Industry Median 3.04%
Annualised payout
0.76
Paid annually
5-Years Growth
+39.80%
Growth Streak

Earnings

Latest Release
Jul 24, 2025
EPS / Forecast
0.42 / --
Revenue / Forecast
160.00M / 161.30M
EPS Revisions
Last 90 days

ROVI Income Statement

People Also Watch

13.475
REP
-2.78%
42.840
ITX
-1.13%
36.500
IDR
+0.94%
13.515
GRLS
+8.99%
11.145
SLRS
+2.53%

FAQ

What Stock Exchange Does Laboratorios Farmaceuticos ROVI Trade On?

Laboratorios Farmaceuticos ROVI is listed and trades on the Vienna Stock Exchange stock exchange.

What Is the Stock Symbol for Laboratorios Farmaceuticos ROVI?

The stock symbol for Laboratorios Farmaceuticos ROVI is "ROVI."

What Is the Laboratorios Farmaceuticos ROVI Market Cap?

As of today, Laboratorios Farmaceuticos ROVI market cap is 2.82B.

What Is Laboratorios Farmaceuticos ROVI's Earnings Per Share (TTM)?

The Laboratorios Farmaceuticos ROVI EPS (TTM) is 2.59.

From a Technical Analysis Perspective, Is ROVI a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Laboratorios Farmaceuticos ROVI Stock Split?

Laboratorios Farmaceuticos ROVI has split 0 times.

How Many Employees Does Laboratorios Farmaceuticos ROVI Have?

Laboratorios Farmaceuticos ROVI has 2188 employees.

What is the current trading status of Laboratorios Farmaceuticos ROVI (ROVI)?

As of 31 Jul 2025, Laboratorios Farmaceuticos ROVI (ROVI) is trading at a price of 55.30, with a previous close of 55.30. The stock has fluctuated within a day range of 55.30 to 55.90, while its 52-week range spans from 45.82 to 88.45.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.